EVERSANA Achieves Key Accreditations for Specialty Pharmacy and Rare Disease Care Excellence
EVERSANA's Commitment to Excellence in Specialty Pharmacy Operations
In a significant achievement, EVERSANA has announced that its specialty pharmacy has received two esteemed recognitions: the URAC Specialty Pharmacy Version 5.0 Accreditation and the URAC Rare Disease Center of Excellence 3.0 Certification. This marks a pivotal moment for the company, as it solidifies its position as a leader in delivering high-quality pharmacy services tailored to meet the needs of patients with rare diseases.
Understanding the Recognitions
The URAC Specialty Pharmacy Version 5.0 Accreditation highlights EVERSANA’s adherence to stringent standards, ensuring that it provides optimal care management and clinical support to its patients. This endorsement signifies that EVERSANA not only meets but exceeds industry benchmarks for specialty pharmacy operations, assuring payers and healthcare providers of its commitment to enhancing patient outcomes.
In addition, the URAC Rare Disease Center of Excellence 3.0 Certification emphasizes EVERSANA’s specialized abilities in addressing the unique challenges faced by patients with rare and complex conditions. Developed with contributions from leading experts, including the National Organization for Rare Disorders, this certification is a testament to the company's dedication to implementing best practices in patient care.
Commitment to Patient-Centric Care
According to Jim Lang, CEO of EVERSANA, these accolades are a reflection of the unwavering commitment that the entire team has towards prioritizing patient needs. Lang stated, “Our team’s commitment to quality and putting the needs of patients first is always unwavering. Receiving these accreditations is a testament to the hard work and dedication of our entire team and validates our efforts to provide exceptional care.”
EVERSANA's specialty pharmacy solutions primarily operate out of the St. Louis, Missouri area and serve over 100,000 patients annually. This tremendous scale not only underscores their capabilities but also highlights the trust and reliance that numerous clients place on EVERSANA’s services.
Building on Existing Accreditations
These new certifications add to EVERSANA's growing list of pharmacy accreditations, including those from the Accreditation Commission for Health Care (ACHC) and the National Association of Boards of Pharmacy (NABP). Each of these accreditations reinforces the level of quality and care EVERSANA continuously strives to deliver.
Looking Ahead
As the healthcare landscape continues to evolve, EVERSANA remains committed to ensuring the highest standards of care for patients with rare diseases. The specialty pharmacy's efforts are aimed at fostering a healthcare environment where patients receive the support they require throughout their treatment journeys.
For more detailed insights about EVERSANA and its extensive patient services, interested parties can visit their website at EVERSANA.com.
As EVERSANA moves forward, the organization is set to integrate these new best practices into its framework, enhancing its offerings and ensuring that patient-centric care remains at the forefront of all endeavors. With such accolades, EVERSANA not only champions quality in specialty pharmacy but also elevates the standard of care for patients facing the complexities of rare diseases.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.